Schedule of Expenses Related to RSUs and RS Granted [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Title and Position [Domain] Antidilutive Securities, Name [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Segment Reporting [Abstract] Antidilutive Securities [Axis] Warrant [Member] Warrant [Member] Option [Member] Restricted Stock Units (RSUs) [Member] RSU [Member] Restricted Stock Units (RSUs) [Member] Basic and Diluted Loss Per Share [Line Items] Compensation expenses Share-Based Payment Arrangement, Expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Total liabilities assumed Business Combination, Recognized Liability Assumed, Liability, Total Total assets acquired and liabilities assumed, net Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), Total Acquired IPR&D BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquiredIPR&D Amount for purchase of IPR&D Total consideration allocated Business Combination, Consideration Transferred, Total Basic and Diluted Loss Per Share (Details) [Table] Basic and Diluted Loss Per Share [Abstract] Loss per share: Number of operating segment Number of Operating Segments Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Approach of CODM to determine segment information Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Number of reportable segment Number of Reportable Segments General [Abstract] GENERAL Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Significant Accounting Policies [Abstract] Shareholders' Equity [Abstract] SHAREHOLDERS’ EQUITY Equity [Text Block] Total Financial Income, Net [Abstract] Equity Components [Axis] Entity Address, Country Entity Address, Country Document Period End Date Document Period End Date Document Quarterly Report Document Quarterly Report Document Type Document Type Entity Central Index Key Entity Central Index Key Document Information [Line Items] Document Information [Table] Cover [Abstract] General (Details) [Table] Income Statement [Abstract] Revenues Revenues Cost of revenues Cost of Revenue Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Decrease (increase) in prepaid expenses and other current assets and other long-term assets Increase (Decrease) in Prepaid Expense and Other Assets Increase in trade payables Increase (Decrease) in Accounts Payable, Trade Decrease in other accounts payable, accrued vacation and recuperation, deferred tax liabilities and accrued expenses Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (decrease) in operating lease right-of-use asset and liability, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Decrease in advances from customers Increase (Decrease) in Contract with Customer, Liability Increase in interest receivable on short-term deposits and restricted bank deposits Increase (Decrease) in Accrued Interest Receivable, Net LOAN FROM THE EIB Long-Term Debt [Text Block] Loan from the EIB [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies [Abstract] INTANGIBLE ASSETS, NET Intangible Asset [Text Block] Intangible Assets, Net [Abstract] Accumulated amortization: SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] (a) Supplemental disclosure of non-cash activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Total cash, cash equivalents, restricted cash and restricted bank deposits Cash, cash equivalents, restricted cash and restricted bank deposits at the beginning of the period Cash, cash equivalents, restricted cash and restricted bank deposits at the end of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Long-term restricted bank deposits Restricted Cash Equivalent Common shares, par value per share (in Dollars per share) Common Stock, Par or Stated Value Per Share Common shares, authorized (in Shares) Common Stock, Shares Authorized Common shares, issued (in Shares) Common Stock, Shares, Issued Less: participation by the National Institute of Allergy and Infectious Diseases, the IIA (each as defined below) and Horizon Europe Research And Development Expenses And Other Parties The amount of participation by the National Institute of Allergy and Infectious Diseases, or NIAID, the Israeli Innovation Authority, or IIA, Horizon Europe and other parties. Research and development expenses, net Research and Development Expense General and administrative expenses General and Administrative Expense Operating loss Operating Income (Loss) Other financial income, net Other Operating Income (Expense), Net Interest expenses related to the Loan (defined below) Interest expense Interest expenses related to the Loan Interest Expense, Nonoperating Total financial income, net Nonoperating Income (Expense) Cash related to Fishway Transaction (defined below) Cash related to Fishway Transaction Amount of cash related to Fishway transactions. Advance payment on account of common shares and warrants reclassification to equity (see note 8(3)) Stock Issuance Value of Common Warrants and Pre-Funded Warrants Equity impact of the value of common warrants and pre-funded warrants. Weighted average number of shares used in computing basic loss per share (in Shares) Weighted average number of shares used in computing basic net loss per share attributable to common shareholders Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares used in computing diluted loss per share (in Shares) Weighted average number of shares used in computing diluted net loss per share attributable to common shareholders Weighted Average Number of Shares Outstanding, Diluted Statement of Stockholders' Equity [Abstract] Statement [Table] Balance Total deficit Balance Equity, Including Portion Attributable to Noncontrolling Interest Balance (in Shares) Common shares, outstanding (in Shares) Balance (in Shares) Common Stock, Shares, Outstanding Share-based compensation to employees, directors, and non-employee consultants (note 8(5)) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Share-based compensation to employees, directors, and non-employee consultants (note 8(5))(in Shares) Stock Issued During Period, Shares, Employee Benefit Plan Issuance of common shares, pre-funded warrants and warrants, net of issuance costs Proceeds from Issuance of Common Stock Alliance Global Partners [Member] Statement [Line Items] Lease liabilities arising from obtaining right-of-use assets Lease Liabilities Arising from Obtaining Right-Of-Use Assets Represent the amount of lease liabilities arising from obtaining right-of-use assets. Basic loss per share (in Dollars per share) Net loss per share attributable to common shareholders - basic (in Dollars per share) Earnings Per Share, Basic Diluted loss per share (in Dollars per share) Net loss per share attributable to common shareholders - diluted (in Dollars per share) Earnings Per Share, Diluted Credit Facility [Axis] Credit Facility [Domain] Finance Contract with EIB [Member] Finance Contract With EIBMember Net loss attributed to shareholders Net loss attributed to shareholders Net loss attributed to non-controlling interest Net Income (Loss) Attributable to Noncontrolling Interest Net loss Incurred losses Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income benefit (taxes) Income Tax Expense (Benefit) Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Subsequent Events [Line Items] Number of shares sold Sold common shares Sale of Stock, Number of Shares Issued in Transaction Offering price Price per share Sale of Stock, Price Per Share Document Fiscal Year Focus Document Fiscal Year Focus Document Transition Report Document Transition Report Advance towards share subscription Advance towards share subscription The amount of advance towards share subscription. Schedule of Expenses Related to RSUs and RS Granted Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Activity Related to RSUs Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block] Schedule of Share Options Granted Share-Based Payment Arrangement, Option, Activity [Table Text Block] Acquired IPR&D related to the Fishway Transaction Acquired IPR&D related to Fishway Transaction (defined below) Acquired in-Process Research and Development, or IPR&D, Related to Fishway Transaction (defined below) Acquired in-process research and development, or IPR&D, related to fishway transaction (defined below). Issuance of Ever After Foods’ (as defined below) shares to non-controlling interests (see note 1e.) Issuance Of Ever After Foods’ (As Defined Below) Shares To Non-Controlling Interests (See Note 8(2)) Amount of issuance of ever after foods’ (as defined below) shares to non-controlling interests (see note 8(2)). Reclassification of advance towards share subscription from liability to equity (see note 8(3)) Reclassification Of Advance Towards Share Subscription From Liability To Equity Reclassification Of Advance Towards Share Subscription From Liability To Equity LIABILITIES AND SHAREHOLDERS’ DEFICIT Liabilities and Equity [Abstract] Unaudited Interim Financial Information Unaudited Interim Financial Information [Policy Text Block] It represents the policy disclosure of Unaudited Interim Financial Information Price per share Offering price per share Shares Issued, Price Per Share Subscription amount The amount of subscription amount. Aggregate subscription amount Aggregate Subscription Amount The amount of aggregate subscription amount. Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Amendment Flag Amendment Flag Document Fiscal Period Focus Document Fiscal Period Focus Non-controlling interests Equity, Attributable to Noncontrolling Interest Total shareholders’ deficit Total shareholders’ equity deficit Equity, Attributable to Parent Accumulated deficit Retained Earnings (Accumulated Deficit) Additional paid-in capital Additional Paid in Capital, Common Stock Common shares, $0.00001 par value per share: Authorized: 37,500,000 as of September 30, 2026, and June 30, 2026; Issued and outstanding: 12,611,335 and 10,824,311 shares as of September 30, 2026, and June 30, 2026, respectively Common Stock, Value, Issued Share capital: Equity, Attributable to Parent [Abstract] SHAREHOLDERS’ DEFICIT Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common Share [Member] Common Stock [Member] Common Shares Common Stock [Member] Consolidated Balance Sheets [Abstract] Total liabilities and deficit Liabilities and Equity COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Property and equipment, net Property And Equipment Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Severance pay fund Assets for Plan Benefits, Defined Benefit Plan Restricted bank deposits Restricted Cash, Noncurrent LONG-TERM ASSETS: Assets, Noncurrent [Abstract] Total current assets Assets, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Cash and cash equivalents Cash, Cash Equivalents, and Short-Term Investments Research and development expenses Research and development expenses Amount of Research and development expenses. Equity Component [Domain] Decrease in accrued severance pay, net Decrease In Accrued Severance Pay Net The amount of decrease in accrued severance pay, net. Net cash used for operating activities Cash flow from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation CASH FLOWS FROM INVESTING ACTIVITIES: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS, restricted cash And restricted bank deposits Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Decrease in cash, cash equivalents, restricted cash and restricted bank deposits Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Reconciliation of cash, cash equivalents, restricted cash and restricted bank deposits reported in the consolidated balance sheets: Supplemental Cash Flow Elements [Abstract] Fair value of financial instruments Fair Value Measurement, Policy [Policy Text Block] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash and cash equivalents Cash Equivalents, at Carrying Value Restricted cash Restricted Cash, Current Percentage of fishway transaction rate Percentage of Fishway Transaction Rate Percentage of fishway transaction rate. Percentage of discount rate Percentage of Discount Rate Percentage of discount rate Percentage of ownership interest Percentage of Ownership Interest Percentage of ownership interest Consideration transferred Consideration Transferred Total consideration transferred Shareholders’ Equity [Table] Stock, Class of Stock [Table] Sale of Stock [Axis] Sale of Stock [Domain] Sales Agreement [Member] Sales Agreement Member Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Pre-Funded Warrants [Member] Pre Funded Warrants Member Schedule Of Share Options Granted Abstract Intangible assets, net Intangible Asset, Finite-Lived, after Accumulated Amortization Total accumulated amortization Intangible Asset, Finite-Lived, Accumulated Amortization Total cost Intangible Asset, Finite-Lived, before Accumulated Amortization Weighted average exercise price, Share options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted average remaining contractual terms (in years), Share options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Aggregate intrinsic value price, Share options vested and exercisable Aggregate intrinsic value of options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Maximum [Member] Maximum [Member] Aggregate purchase price Business Combination, Price of Acquisition, Expected Advance Subscription Agreement [Member] Advance Subscription Agreement [Member] Financial Instrument [Axis] Financial Instruments [Domain] Short-Term Debt [Member] CEO And Directors [Member] CEO And Directors [Member] Vesting [Axis] Vesting [Domain] First Tranche [Member] Share-Based Payment Arrangement, Tranche One [Member] Exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Gross proceeds Proceeds from Issuance Initial Public Offering RSUs granted Granted, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Cost: Intangible Asset, Finite-Lived, before Accumulated Amortization [Abstract] Schedule of Intangible Assets, Net [Abstract] Debt Instrument [Axis] Percentage of RSU vest Percentage of RSU vest. First Year [Member] General [Line Items] Percentage of annual interest rate Line of Credit Facility, Interest Rate During Period Balance of principal and interest accrued Line of Credit Facility, Increase, Accrued Interest Amortization expenses Amortization Impairment losses Intangible Asset, Excluding Goodwill, Impairment Loss Royalties revenues percentage Royalties Revenues Percentage Percentage of royalties revenue. Aggregate royalty amount Royalty Guarantees, Commitments, Amount Loan from the EIB (Details) [Table] Purchase up to shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Third Year [Member] Second Year [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement Member Aggregate intrinsic value price, Share options outstanding at beginning of period Aggregate intrinsic value price, Share options outstanding at end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Weighted average remaining contractual terms (in years), Share options outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Weighted average exercise price, Share options outstanding at beginning of period Weighted average exercise price, Share options outstanding at end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Loan amount (in Euro) Subsidiary obtain loan amount (in Euro) Line of Credit Facility, Maximum Borrowing Capacity Initial fair value recognition Initial Fair Value Recognition SAFE Instrument Amount of initial fair value recognition SAFE instrument. SAFE balance at the beginning of year Balance as of September 30, 2026 SAFE Instrument Amount of SAFE instrument. Safe [Table] SAFE [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Schedule of SAFE Instrument Schedule of SAFE Instrument [Table Text Block] Tabular disclosure of SAFE instrument. Schedule Of Activity Related To Unvested Rsus And Rs Granted Abstract Title and Position [Axis] Forfeited, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Vested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Unvested at the end of the period, Number Unvested at the beginning of period, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Expected to vest after the end of period, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Schedule of Total Financial Income, Net [Abstract] Foreign exchange gains (losses), net Gain (Loss), Foreign Currency Transaction, before Tax Interest income on deposits and restricted bank deposits Interest Income, Deposits with Financial Institutions Income from hedging derivatives Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives Schedule of Computation of Basic and Diluted Loss Per Share [Abstract] Numerator: Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract] Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Unexercised vested options with no par value exercise price Unexercised Vested Options With No Par Value Exercise Price Unexercised vested options with no par value exercise price. Pre-funded warrants to purchase common shares Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Common shares outstanding used in computing net loss per share attributable to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Interest income Investment Income, Interest Share-based compensation expenses Share-Based Payment Arrangement, Expense, after Tax Depreciation and amortization expenses Depreciation, Depletion and Amortization, Nonproduction Other segment disclosures: Segment Reporting, Reconciliation of Other Item by Segment to Consolidated [Abstract] Other segment items Segment Reporting, Other Segment Item, Amount Unvested RSUs Granted to Employees and Directors [Member] Unvested RSUs Granted To Employees And Directors Member Unvested RSUs and RS Granted to Non-Employee [Member] Unvested RSUs And RSGranted To Non Employee Member Schedule of Activity Related to Unvested RSUs and RS Granted [Line Items] Schedule of Share Options Granted [Line Items] Schedule of Share Options Granted [Line Items] Share-Based Payment Arrangement, Disclosure [Abstract] Location, Statement of Income, Balance [Axis] Materials Cost, Direct Material Professional services expenses Professional Fees Salary expenses Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold Revenues from external customers Revenues From External Customers Revenues from external customers. Capital raised amount Theamountofcapitalraise The amount of capital raise Advance towards share subscription to purchase common shares Advance Towards Share Subscription To Purchase Common Shares Amount of advance towards share subscription to purchase common shares. Safe [Abstract] Diluted loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Other financial income, net Other Nonoperating Income (Expense) SAFE agreement [Member] SAFEAgreement Member Aggregate amount Aggregate Amount The amount of aggregate. Raised capital percentage Raised Capital Percentage Raised capital percentage. Advance Towards Share Subscription [Abstract] ADVANCE TOWARDS SHARE SUBSCRIPTION Advance Towards Share Subscription [Text Block] Advance Towards Share Subscription. Purchaser advance The amount of purchaser advance. Business Combination [Table] Business Combination [Axis] Business Combination [Domain] Fishway Transaction [Member] Schedule of Assets Acquired, Liabilities Assumed [Line Items] Business Combination [Line Items] Cash and Cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Restricted bank deposits BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedBankDeposits Amount of restricted deposits. Property and equipment, net Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment, Total Prepaid expenses and other current assets Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current Total assets acquired Business Combination, Recognized Asset Acquired, Asset, Total Trade payables Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Trade Payables Amount of trade payables. Convertible loan BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConvertibleLoan Amount of convetible loan. Other accounts payable Business Combination, Recognized Liability Assumed, Accounts Payable, Current Proceeds from short-term deposits, net Proceeds from Sale of Short-Term Investments Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation CASH FLOWS FROM FINANCING ACTIVITIES: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Proceeds from SAFE Proceeds From SAFE Amount of cash inflow received from SAFE, classified as a long-term liability. Total long-term liabilities Liabilities, Noncurrent Simple Agreement for Future Equity, or SAFE Preferred Stock, Value, Issued Incorporated date Entity Incorporation, Date of Incorporation Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code TOTAL FINANCIAL INCOME, NET Other Income and Other Expense Disclosure [Text Block] SEGMENT REPORTING Segment Reporting [Text Block] Subsequent Event Type [Domain] Pluri Biotech [Member] Ownership [Domain] Ownership [Axis] Securities holding percentage Subsidiary, Ownership Percentage, Parent Repayment of convertible loan related to Fishway Transaction (defined below) Repayment of convertible loan related to Fishway Transaction Represents the amount of repayment of convertible loan related to Fishway Transaction. Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Purchase Agreements [Member] Securities Purchase Agreements [Member] Outstanding percent Sale of Stock, Percentage of Ownership after Transaction Expire term Warrants and Rights Outstanding, Term Schedule of Intangible Assets, Net Intangible Asset, Finite-Lived [Table Text Block] Use of estimates Use of Estimates, Policy [Policy Text Block] Significant Accounting Policies Basis of Accounting, Policy [Policy Text Block] Statement of Cash Flows [Abstract] Net of issuance costs Net Of Issuance Costs The amount of net of issuance costs. Subsequent Events [Abstract] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Entity Common Stock, Shares Outstanding Advances for property and equipment Advances For Property And Equipment Sum of the carrying amounts paid in advance for physical assets that are expected to be used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Accrued expenses Accrued Liabilities, Current Operating lease liability Operating Lease, Liability, Current Accrued vacation and recuperation Accrued Vacation and Recuperation Current Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Advances from customers Advances From Customers Current Represents the amount of advances from customers. Loan from the European Investment Bank, or EIB Loans Payable to Bank, Current Other accounts payable Accounts Payable, Other, Current Schedule of Computation of Basic and Diluted Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Segment Expenses Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block] BASIC AND DILUTED LOSS PER SHARE Earnings Per Share [Text Block] Increase in customer receivable Increase (Decrease) in Accounts and Other Receivables Share-based compensation to employees, directors and non-employee consultants Share-Based Payment Arrangement, Noncash Expense Depreciation and amortization Depreciation, Depletion and Amortization Adjustments to reconcile loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Deferred tax liabilities Deferred Income Tax Liabilities, Net Operating lease liability Operating Lease, Liability, Noncurrent Accrued severance pay Postemployment Benefits Liability, Noncurrent LONG-TERM LIABILITIES Liabilities, Noncurrent [Abstract] Total current liabilities Liabilities, Current Schedule of Total Financial Income, Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] SAFE Collaborative Arrangement Disclosure [Text Block] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Trade payables Accounts Payable, Trade, Current CURRENT LIABILITIES Liabilities, Current [Abstract] Total assets Assets Total long-term assets Assets, Noncurrent Other long-term assets Other Assets, Noncurrent Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Goodwill Goodwill Intangible assets, net Intangible Assets Net Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Increase in short-term interest payable and exchange rate differences related to the EIB loan, net Increase (Decrease) in Interest Payable, Net Effect of exchange rate changes on cash, cash equivalents, deposits, restricted cash and restricted bank deposits Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation CASH FLOWS FROM OPERATING ACTIVITIES: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Issuance of common shares, Common Warrants and Pre-Funded Warrants (each as defined below), net of issuance costs of $349 (see note 8(2)) (in Shares) Stock Issued During Period Shares Issuance Of Common Shares And Warrants The number of shares of issuance of common shares and warrants, net of issuance costs. Issuance of common shares, Common Warrants and Pre-Funded Warrants (each as defined below), net of issuance costs of $349 (see note 8(2)) Stock Issued During Period Value Issuance Of Common Shares And Warrants The amount of issuance of common shares and warrants. Exercise of Pre-Funded Warrants (see note 8(2))) (in Shares) Stock Issued During Period Shares Prefunded Warrants Stock issued during period, shares pre-funded warrants. Exercise of Pre-Funded Warrants (see note 8(2)) Stock Issued During Period Value Exercise Of Prefunded Warrants Represent the amount of exercise of pre-funded warrants. Issuance of common shares under the Sales Agreement (as defined below) with Alliance Global Partners, or A.G.P., net of issuance costs of $19 (see note 8(1)) (in Shares) Stock Issued During Period Shares Issuance Of Common Shares Under ASales Agreement Number of shares issued issuance of common shares under a sales agreement with A.G.P./Alliance Global Partners, or A.G.P. Issuance of common shares under the Sales Agreement (as defined below) with Alliance Global Partners, or A.G.P., net of issuance costs of $19 (see note 8(1)) Stock Issued During Period, Value, New Issues Non-controlling Interests Noncontrolling Interest [Member] Total Shareholders’ Equity (Deficit) Parent [Member] Accumulated Deficit Retained Earnings [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Customer receivables, net Receivable from Customer in Brokerage City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Safe [Line Items] Change in fair value Fair Value, Option, Changes in Fair Value, Gain (Loss) Subsequent Events (Details) [Table] Subsequent Event Type [Axis] Subsequent Event [Member] Subsequent Event [Member] Fishway Transaction (see note 1e.) Fishway Transaction Fishway transaction amount. Convertible loan Convertible Loan Amount of debt. Current Fiscal Year End Date Current Fiscal Year End Date ASSETS Assets [Abstract] CURRENT ASSETS: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalent Short-term bank deposits Deposits Assets, Current Gross proceeds Proceeds from Issuance of Warrants Common Warrants [Member] Common Warrants Member Loan from the EIB [Line Items] Number, Share options outstanding at end of the period Number, Share options outstanding at beginning of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance RS Granted [Member] RSGranted Member RSUs and RS [Member] RSUs And RSMember Interest accrued (in Dollars) Debt Instrument, Increase, Accrued Interest Principal balance (in Dollars) Investment Owned, Balance, Principal Amount Annual interest percentage Debt Instrument, Interest Rate, Effective Percentage Due date Due Date Due date. Consolidated revenues Debt Instrument, Face Amount Accrued royalty (in Dollars) Accrued Royalties Consolidated revenues percentage Debt Instrument, Interest Rate, Stated Percentage Exercisable warrant term Exercisable Warrant Term Term of exercisable warrant. Loan from EIB [Member] Loan From EIBMember Annual Interest [Member] Annual Interest Member Royalties [Member] Royalties Member Debt Instrument, Name [Domain] Second Offering Warrants [Member] Number, Share options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Principal aggregate amount Debt Instrument, Issued, Principal Schedule of Assets Acquired, Liabilities Assumed Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Number, Share options expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Weighted average exercise price, Share options expired Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average remaining contractual terms (in years), Share options expired Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Terms In Years Share Options Expired Weighted average remaining contractual term for option awards share options expired. Non-Employee [Member] Share-Based Payment Arrangement, Nonemployee [Member] Schedule of Intangible Assets, Net [Line Items] Intangible Asset, Finite-Lived [Line Items] Ability to develop additional applications [Member] Ability To Develop Additional Applications Member Cocoa cell growth and application platform [Member] Cocoa Cell Growth And Application Platform Member Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived [Table] Compensation Expense Category [Domain] Compensation Expense Category [Axis] Compensation Expense Category Axis Stock Options [Member] Equity Option [Member] Derivative Contract [Domain] Derivative Instrument [Axis] Royalties revenues term Royalties Revenues Term Royalties revenues term. Weighted average grant date fair value (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Compensation expenses Employee Benefits and Share-Based Compensation Issuance expenses Payments of Stock Issuance Costs Aggregate offering price Sale of Stock, Consideration Received on Transaction Shareholders’ Equity [Line Items] Prepaid Expenses and Other Current Assets [Member] Prepaid Expense And Other Current Assets Member Marketing and business development activities Marketing And Business Development Activities Contingent liability in respect to royalties Contingent Liability In Respect To Royalties The amount of contingent liability in respect to royalties. Royalty payable based on grants received Royalty Rate Payable On Grants Received Royalty payable based on grants received. Royalty rate Royalty Rate Sales Royalty rate payable calculated as a percentage of the sale of products and other related revenues generated from such projects. Percentage of qualified expenditures eligible for grant Percentage Of Qualified Expenditures Percentage Of Qualified Expenditures. Cash and restricted cash Restricted Cash and Cash Equivalent CEO